Updating the investing public regarding the 2023 Business Plan.
Read More
Results of the Extraordinary General Meeting of the Company have been published
Read More
The Interim Financial Statements 2023 have been approved.
Read More
The Company has successfully listed its second tranche of Bonds on the CSE.
Read More
Calling of the Extraordinary General Meeting of the Company
Read More
The Company has proceeded with the issue and allotment of a second tranche of Bonds
Read More
See the Company’s press release regarding its participation at the 31st National Psychiatric Summit
Read More
The results of the Annual General Meeting of the Company are available
Read More
The Greek NHS has approved the coverage of PGx-CNS product
Read More
iDNA Genomics Public Ltd successfully lists Bond 2028 on the CSE
Read More
Materials for Annual General Meeting of the Company 2023
Read More
Approval of financial statements 2022 and date set for AGM 2023
Read More